CONTACT US OR CALL 1.866.416.4636

Join Customer Site
Seeing More Matters
Call us at: 1.866.416.4636 | Europe: 00.800.0751.2020
  • Join
  • Customer Site

Translational Cancer imaging in preclinical animal models

What can the Vevo Imaging systems do for Oncology?


The Vevo Imaging systems is the leader in cutting edge in vivo imaging solution with high frequency ultrasound and photoacoustic imaging. Cancer researchers are empowered with unique solutions to meet the translational priorities in research towards precision medicine. The Vevo research community has witnessed over 300 cancer publications and latest breakthroughs in targeted therapeutics.


Cancer is a complex disease, and cancer research needs an advanced imaging solution. Today’s cancer researcher can visualize cancer in all its dimensions and in models that are relevant to human cancer. Deep tissue non-invasive imaging of cancers in soft tissues uniquely positions the Vevo for Oncology. Combine that with imaging the microenvironment for changes in angiogenesis, hypoxia and molecular markers, drug delivery, to name a few, make the Vevo Imaging systems the first choice for Oncology research, in the age of precision medicine.


Screen and quantify tumor in all its dimensions – Learn more about VevoLAZR to get 5 data sets from one scan.

  • + High resolution assessment of primary and metastatic burden in soft tissues
    • Non-invasive and longitudinal visualization of micro margins of pre-palpable tumors
    • Deep tissue resolution(down to 30 microns) of orthotopic tumors without injectable contrast.
    • Translatable measurements of the tumor dimensions
  • + Rapid assessment on quality of predictive models and experimental therapeutics in minutes
  • + Multimodal investigation on microenvironment with a histology guided approach
    • Non-invasive visualization and quantitation of microvascular change in user defined step sections ranging from 50 microns.
    • Detect live change early in microvascular density, perfusion and molecular oxygenation (Oxyhemo) in one imaging session
  • + Non Invasive investigation of translational molecular biomarkers in situ